Chris French
Directeur Technique/Scientifique/R&D chez CHECKMATE PHARMACEUTICALS, INC.
Provenance du réseau au premier degré de Chris French
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Biotechnology | 24 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Chris French via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
University of California, Berkeley | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Founder General Counsel | |
University of Iowa | College/University | Corporate Officer/Principal Undergraduate Degree | |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree | |
Biomarker Science Group LLC | Director/Board Member | ||
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Strata Oncology, Inc.
Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Strata Oncology, Inc. manufactures oncology drugs. It provides comprehensive testing, portfolio of treatments, peace of mind. The company was founded by Daniel D. Rhodes, Scott Tomlin and Keith T. Flaherty in 2015 and is headquartered Ann Arbor, MI. | Pharmaceuticals: Major | Founder | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Founder | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Apricity Health LLC
Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Apricity Health LLC is a digital health company that aims to bridge the gap between academic specialty care and real-world practice. The company is based in Houston, TX. Apricity Health is committed to disseminating clinical expertise to benefit patients everywhere, especially those without access to subspecialty care. Apricity Health develops digital solutions to make novel life-saving cancer therapies safer, better, and more accessible to patients. The company was founded by world-renowned physician scientists in cancer and immuno-oncology, including Keith T. Flaherty, James Allison, Lynda Chin, and Padmanee Sharma. Lynda Chin has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Clinical Cancer Research | Corporate Officer/Principal | ||
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Canbex Therapeutics Ltd.
Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Analyst | |
Ariagen, Inc.
Ariagen, Inc. Financial ConglomeratesFinance Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono. | Financial Conglomerates | Chief Executive Officer | |
National Institute of Arthritis | General Government | Corporate Officer/Principal | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
Etats-Unis | 48 |
Royaume-Uni | 3 |
Suisse | 2 |
Sectorielle
Health Technology | 29 |
Consumer Services | 12 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 128 |
Corporate Officer/Principal | 61 |
Director of Finance/CFO | 30 |
Independent Dir/Board Member | 27 |
Undergraduate Degree | 22 |
Relations les plus connectées
Insiders | |
---|---|
Michael Powell | 48 |
Corey Goodman | 35 |
Robert Mark Weisskoff | 34 |
Nilesh Kumar | 26 |
Alan Fuhrman | 17 |
Keith Flaherty | 16 |
Jonathan Lieber | 16 |
Jon Wigginton | 13 |
Barry A. Labinger | 12 |
Arthur M. Krieg | 10 |
Katherine Eade | 10 |
David Mauro | 9 |
Robert Landry | 8 |
Peter Colabuono | 8 |
Robert Dolski | 8 |
- Bourse
- Insiders
- Chris French
- Connexions Sociétés